Europe Syringe Infusion Pump Market Size, Share & Trends Analysis Report By Disease Indication (Chemotherapy, Gastroenterology, Hematology), By End-use, By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Europe Syringe Infusion Pump Market Growth & Trends
The Europe syringe infusion pump market size is anticipated to reach USD 729.5 million by 2030 and is projected to grow at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of preterm births, the rising prevalence of chronic diseases, and healthcare providers' focus on incorporating advanced technology-driven equipment are leading to growth in the adoption of syringe infusion pumps in Europe.
Growing new cases of cancer, a significant increase in patients diagnosed with diabetes, and continuous growth in patients admitted to intensive care units for treatments associated with complex health conditions are expected to generate growth for this market. The launch of innovation-based products with key features such as real-time monitoring and control devices is expected to drive growth and adoption across hospitals and healthcare facilities.
Significant advancements driven by innovation, research-based product developments, and stringent regulatory requirements regarding the safety and quality of medical devices and equipment are expected to influence this market positively. The rising adoption of controlled delivery of medications and precision dosing in critical care applications is anticipated to create lucrative growth opportunities over the forecast period.
Europe Syringe Infusion Pump Market Report Highlights
B. Braun SE
Baxter
BD
Fresenius Kabi AG
Micrel Medical Devices SA
CODAN Companies
Arcomed
ICU Medical, Inc. (Smiths Medical)
Terumo Corporation
Moog Inc.
Europe Syringe Infusion Pump Market Growth & Trends
The Europe syringe infusion pump market size is anticipated to reach USD 729.5 million by 2030 and is projected to grow at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of preterm births, the rising prevalence of chronic diseases, and healthcare providers' focus on incorporating advanced technology-driven equipment are leading to growth in the adoption of syringe infusion pumps in Europe.
Growing new cases of cancer, a significant increase in patients diagnosed with diabetes, and continuous growth in patients admitted to intensive care units for treatments associated with complex health conditions are expected to generate growth for this market. The launch of innovation-based products with key features such as real-time monitoring and control devices is expected to drive growth and adoption across hospitals and healthcare facilities.
Significant advancements driven by innovation, research-based product developments, and stringent regulatory requirements regarding the safety and quality of medical devices and equipment are expected to influence this market positively. The rising adoption of controlled delivery of medications and precision dosing in critical care applications is anticipated to create lucrative growth opportunities over the forecast period.
Europe Syringe Infusion Pump Market Report Highlights
- Based on disease type, the pediatrics/neonatology segment led the market with the largest revenue share of 26.2% in 2024, owing to the significant assistance of syringe infusion pumps in controlled drug delivery while treating newborns and advanced technological capabilities.
- The chemotherapy segment is projected to experience at the fastest CAGR over the forecast period.
- The increasing incidence of chronic disease, primarily cancer, and the growing integration of palliative care with cancer treatments fuel the market growth.
- Based on end use, the hospitals segment accounted for the largest market revenue share in 2024, owing to their increasing application in multiple treatments that require precision dosing and controlled drug delivery.
- The home care segment is projected to grow at the fastest CAGR from 2025 to 2030
- Germany dominated the market with the largest revenue share in 2024, with multiple manufacturers and growing applications in intensive and critical care, chemotherapy, pain management, and other areas.
B. Braun SE
Baxter
BD
Fresenius Kabi AG
Micrel Medical Devices SA
CODAN Companies
Arcomed
ICU Medical, Inc. (Smiths Medical)
Terumo Corporation
Moog Inc.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Indication
1.2.2. End Use
1.2.3. Country scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease indication outlook
2.2.2. End use outlook
2.2.3. Country outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE SYRINGE INFUSION PUMPS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Europe Syringe Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
CHAPTER 4. EUROPE SYRINGE INFUSION PUMPS MARKET: DISEASE INDICATION ESTIMATES & TREND ANALYSIS
4.1. Disease Indication Segment Dashboard
4.2. Europe Syringe Infusion Pumps Market: Disease Indication Movement Analysis
4.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
4.4. Chemotherapy
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Diabetes
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Gastroenterology
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Analgesia/Pain Management
4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Pediatrics/Neonatology
4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Hematology
4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE SYRINGE INFUSION PUMPS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. End Use Segment Dashboard
5.2. Europe Syringe Infusion Pumps Market: End Use Movement Analysis
5.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE SYRINGE INFUSION PUMPS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Country Market Dashboard
6.2. Country Market Share Analysis, 2024 & 2030
6.3. Europe Syringe Infusion Pumps Market, By Country: Key Takeaways
6.4. Germany
6.4.1. Key country dynamics
6.4.2. Regulatory framework/ reimbursement structure
6.4.3. Competitive scenario
6.4.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. UK
6.5.1. Key country dynamics
6.5.2. Regulatory framework/ reimbursement structure
6.5.3. Competitive scenario
6.5.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. France
6.6.1. Key country dynamics
6.6.2. Regulatory framework/ reimbursement structure
6.6.3. Competitive scenario
6.6.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Italy
6.7.1. Key country dynamics
6.7.2. Regulatory framework/ reimbursement structure
6.7.3. Competitive scenario
6.7.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Spain
6.8.1. Key country dynamics
6.8.2. Regulatory framework/ reimbursement structure
6.8.3. Competitive scenario
6.8.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Denmark
6.9.1. Key country dynamics
6.9.2. Regulatory framework/ reimbursement structure
6.9.3. Competitive scenario
6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Norway
6.10.1. Key country dynamics
6.10.2. Regulatory framework/ reimbursement structure
6.10.3. Competitive scenario
6.10.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.11. Sweden
6.11.1. Key country dynamics
6.11.2. Regulatory framework/ reimbursement structure
6.11.3. Competitive scenario
6.11.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Baxter
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. BD
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Fresenius Kabi AG
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Micrel Medical Devices SA
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. CODAN Companies
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Arcomed
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. ICU Medical, Inc. (Smiths Medical)
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Terumo Corporation
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Moog Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Indication
1.2.2. End Use
1.2.3. Country scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease indication outlook
2.2.2. End use outlook
2.2.3. Country outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE SYRINGE INFUSION PUMPS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Europe Syringe Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
CHAPTER 4. EUROPE SYRINGE INFUSION PUMPS MARKET: DISEASE INDICATION ESTIMATES & TREND ANALYSIS
4.1. Disease Indication Segment Dashboard
4.2. Europe Syringe Infusion Pumps Market: Disease Indication Movement Analysis
4.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
4.4. Chemotherapy
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Diabetes
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Gastroenterology
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Analgesia/Pain Management
4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Pediatrics/Neonatology
4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Hematology
4.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE SYRINGE INFUSION PUMPS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. End Use Segment Dashboard
5.2. Europe Syringe Infusion Pumps Market: End Use Movement Analysis
5.3. Europe Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Homecare
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE SYRINGE INFUSION PUMPS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Country Market Dashboard
6.2. Country Market Share Analysis, 2024 & 2030
6.3. Europe Syringe Infusion Pumps Market, By Country: Key Takeaways
6.4. Germany
6.4.1. Key country dynamics
6.4.2. Regulatory framework/ reimbursement structure
6.4.3. Competitive scenario
6.4.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. UK
6.5.1. Key country dynamics
6.5.2. Regulatory framework/ reimbursement structure
6.5.3. Competitive scenario
6.5.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. France
6.6.1. Key country dynamics
6.6.2. Regulatory framework/ reimbursement structure
6.6.3. Competitive scenario
6.6.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Italy
6.7.1. Key country dynamics
6.7.2. Regulatory framework/ reimbursement structure
6.7.3. Competitive scenario
6.7.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Spain
6.8.1. Key country dynamics
6.8.2. Regulatory framework/ reimbursement structure
6.8.3. Competitive scenario
6.8.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Denmark
6.9.1. Key country dynamics
6.9.2. Regulatory framework/ reimbursement structure
6.9.3. Competitive scenario
6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Norway
6.10.1. Key country dynamics
6.10.2. Regulatory framework/ reimbursement structure
6.10.3. Competitive scenario
6.10.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.11. Sweden
6.11.1. Key country dynamics
6.11.2. Regulatory framework/ reimbursement structure
6.11.3. Competitive scenario
6.11.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. B. Braun SE
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Baxter
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. BD
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Fresenius Kabi AG
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Micrel Medical Devices SA
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. CODAN Companies
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Arcomed
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. ICU Medical, Inc. (Smiths Medical)
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Terumo Corporation
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Moog Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 Europe syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 3 Europe syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 4 Europe syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 5 Germany syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 6 Germany syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 7 UK syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 8 UK syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 9 France syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 10 France syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 11 Italy syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 12 Italy syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 13 Spain syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 14 Spain syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 15 Denmark syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 16 Denmark syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 17 Norway syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 18 Norway syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 19 Sweden syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 20 Sweden syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 Europe syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 3 Europe syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 4 Europe syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 5 Germany syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 6 Germany syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 7 UK syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 8 UK syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 9 France syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 10 France syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 11 Italy syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 12 Italy syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 13 Spain syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 14 Spain syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 15 Denmark syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 16 Denmark syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 17 Norway syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 18 Norway syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 19 Sweden syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 20 Sweden syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe syringe infusion pumps market: market outlook
Fig. 10 Europe syringe infusion pumps competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Europe syringe infusion pumps market driver impact
Fig. 16 Europe syringe infusion pumps market restraint impact
Fig. 17 Europe syringe infusion pumps market strategic initiatives analysis
Fig. 18 Europe syringe infusion pumps market: Disease indication movement analysis
Fig. 19 Europe syringe infusion pumps market: Disease indication outlook and key takeaways
Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
Fig. 21 Diabetes estimates and forecast, 2018 - 2030
Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
Fig. 25 Hematology estimates and forecast, 2018 - 2030
Fig. 26 Others estimates and forecast, 2018 - 2030
Fig. 27 Europe syringe infusion pumps market: End use movement analysis
Fig. 28 Europe syringe infusion pumps market: End use outlook and key takeaways
Fig. 29 Hospitals estimates and forecast, 2018 - 2030
Fig. 30 Homecare estimates and forecast, 2018 - 2030
Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
Fig. 32 Europe syringe infusion pumps market: Country movement analysis
Fig. 33 Europe syringe infusion pumps market: Country outlook and key takeaways
Fig. 34 Germany market estimates and forecasts, 2018 - 2030
Fig. 35 UK market estimates and forecasts, 2018 - 2030
Fig. 36 France market estimates and forecasts, 2018 - 2030
Fig. 37 Italy market estimates and forecasts, 2018 - 2030
Fig. 38 Spain market estimates and forecasts, 2018 - 2030
Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
Fig. 40 Norway market estimates and forecasts, 2018 - 2030
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe syringe infusion pumps market: market outlook
Fig. 10 Europe syringe infusion pumps competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Europe syringe infusion pumps market driver impact
Fig. 16 Europe syringe infusion pumps market restraint impact
Fig. 17 Europe syringe infusion pumps market strategic initiatives analysis
Fig. 18 Europe syringe infusion pumps market: Disease indication movement analysis
Fig. 19 Europe syringe infusion pumps market: Disease indication outlook and key takeaways
Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
Fig. 21 Diabetes estimates and forecast, 2018 - 2030
Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
Fig. 25 Hematology estimates and forecast, 2018 - 2030
Fig. 26 Others estimates and forecast, 2018 - 2030
Fig. 27 Europe syringe infusion pumps market: End use movement analysis
Fig. 28 Europe syringe infusion pumps market: End use outlook and key takeaways
Fig. 29 Hospitals estimates and forecast, 2018 - 2030
Fig. 30 Homecare estimates and forecast, 2018 - 2030
Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
Fig. 32 Europe syringe infusion pumps market: Country movement analysis
Fig. 33 Europe syringe infusion pumps market: Country outlook and key takeaways
Fig. 34 Germany market estimates and forecasts, 2018 - 2030
Fig. 35 UK market estimates and forecasts, 2018 - 2030
Fig. 36 France market estimates and forecasts, 2018 - 2030
Fig. 37 Italy market estimates and forecasts, 2018 - 2030
Fig. 38 Spain market estimates and forecasts, 2018 - 2030
Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
Fig. 40 Norway market estimates and forecasts, 2018 - 2030
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
